Trump signs order raising Canada tariffs to 35% from 25%
Michael Burkes, the Chief Financial Officer of Natera, Inc. (NASDAQ:NTRA), recently sold shares of the company’s common stock. According to a filing with the Securities and Exchange Commission, Burkes sold 1,442 shares on January 27, 2025, at a price of $161.87 per share, amounting to a total transaction value of $233,416. The sale comes as Natera’s stock has shown remarkable performance, with a 154% return over the past year and the company maintaining strong financial health according to InvestingPro data.
Following this transaction, Burkes holds 108,032 shares of Natera, which now commands a market capitalization of $22.2 billion. The sale was conducted under a Rule 10b5-1 trading plan, which had been adopted on March 14, 2023. This plan allows insiders to set up a predetermined schedule for selling stocks, helping them avoid concerns about insider trading. For deeper insights into insider transactions and comprehensive financial analysis, InvestingPro subscribers can access detailed Pro Research Reports covering over 1,400 top stocks, including Natera.
In other recent news, Natera Inc . has seen significant developments. The company reported a record Q3 revenue of $439.8 million, marking a 64% increase year-over-year, and conducted 137,000 oncology tests. In terms of analyst ratings, Canaccord Genuity maintained a Buy rating on Natera’s stock with a $180 target, while Barclays (LON:BARC) upgraded the rating to Overweight with a $200 target. On the other hand, TD Cowen reiterated a Buy rating, raising the price target from $175 to $195.
Natera also broadened its patent infringement litigation against NeoGenomics (NASDAQ:NEO), involving the RaDaR assay. Despite a setback in a false advertising lawsuit against Guardant Health (NASDAQ:GH), Natera plans to request the court to overturn the ruling. Finally, an agreement with Dr. Rabinowitz, the Executive Chairman, was amended for him to continue his role under certain conditions. These are the recent developments in Natera’s ongoing operations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.